OBJECTIVE: The ketogenic diet (KD) is a diet low in carbohydrates and rich in fats which has long been used to treat refractory epilepsy. The metabolic changes related to the KD may increase the risk of hypoglycemia, especially during the first days. The study focused on the impact of KD initiation on glycemia in non-diabetic patients with refractory epilepsy. METHODS: The subjects were 10 pediatric patients (6 boys, mean age 6.1 ± 2.4 years), treated for intractable epilepsy. Blinded continuous glucose monitoring system (CGM) Dexcom G4 was used. Patients started on their regular diet in the first 36 hours of monitoring, followed by an increase in lipids intake and a gradual reduction of carbohydrates (relations 1:1; 2:1; 3:1; 3.5:1). We analyzed changes in glycemia during fat: nonfat ratio changes using a generalized linear model. RESULTS: The mean monitored time per person was 6 days, 10 hours and 44 minutes. The mean ± SD glycemia for the regular diet was 4.84 ± 0.20 mmol/L, for the carbohydrates/fat ratio of 1:1 it was 4.03 ± 0.16, for the ratio of 2:1 it was 3.57 ± 0.10, for the ratio 3:1 it was 3.39 ± 0.13 and for the final ratio of 3.5:1 it was 2.79 ± 0.06 mmol/L (P < 0.001). The portions of time spent in glycemia ≤3.5 mmol/L (≤2.5 mmol/L respectively) were: on the normal diet 0.88% (0.31%) of the monitored period, during 1:1 KD ratio 1.92% (0.95%), during 2:1 ratio 3.18% (1.02%), and during 3:1 and 3.5:1 ratios 13.64% (2.36%) of the monitored time (P < 0.05). SIGNIFICANCE: Continuous glucose monitoring system shows the dynamic of glucose concentration in ketogenic diet treatment initiation. It may be a useful tool to control the effects of this diet on glucose metabolism, especially in hypoglycemia detection.

3rd Medical Faculty Charles University Prague Czech Republic

Center of Nutrition Thomayer University Hospital Prague Czech Republic

Department of Internal Medicine 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Internal Medicine 3rd Faculty of Medicine Charles University and Thomayer University Hospital Prague Czech Republic

Department of Pediatric Neurology Thomayer University Hospital Prague Czech Republic

Institute of Computer Science Academy of Science of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Martin‐McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Ketogenic diet for drug resistant epilepsy. Cochrane Database Syst Rev. 2018;11:CD001903. PubMed PMC

de Campo DM, Kossoff EH. Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care. 2019;22:264–8. PubMed

Rho JM. How does the ketogenic diet induce anti‐seizure effects? Neurosci Lett. 2017;637:4–10. PubMed

Schwartz RH, Eaton J, Bower BD, Aynsley‐Green A. Ketogenic diets in the treatment of epilepsy: short‐term clinical effects. Dev Med Child Neurol. 1989;31:145–51. PubMed

Schwartz RM, Boyes S, Aynsley‐Green A. Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Dev Med Child Neurol. 1989;31:152–60. PubMed

Cai QY, Zhou ZJ, Luo R, Gan J, Li SP, Mu DZ, et al. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017;13(6):528–36. PubMed

Brožová K, Holubová A, Bořilová P, Brabec M, Kohout P, Hadač J, et al. Hypoglycemia during treatment with the ketogenic diet in a child with refractory epilepsy‐results of continuous glucose monitoring. Neuro Endocrinol Lett. 2021;42(4):277–81. PubMed

Schiller K, Avigdor T, Kortas A, Kunz M, Unterholzner G, Klingelhöfer M, et al. Monitoring glucose concentrations in children with epilepsy on a ketogenic diet. Healthcare. 2022;10(2):245. 10.3390/healthcare10020245 PubMed DOI PMC

Holubová A, Vlasáková M, Mužík J, Brož J. Customizing the types of technologies used by patients with type 1 diabetes mellitus for diabetes treatment: case series on patient experience. JMIR Mhealth Uhealth. 2019;7(7):e11527. 10.2196/11527 PubMed DOI PMC

Brož J, Janíčková Žďárská D, Urbanová J, Brabec M, Doničová V, Štěpánová R, et al. Current level of glycemic control and clinical inertia in subjects using insulin for the treatment of type 1 and type 2 diabetes in The Czech Republic and the Slovak Republic: results of a multinational, multicenter, observational survey (DIAINFORM). Diabetes Ther. 2018;9(5):1897–906. PubMed PMC

Mian Z, Hermayer KL, Jenkins A. Continuous glucose monitoring: review of an innovation in diabetes management. Am J Med Sci. 2019;358(5):332–9. 10.1016/j.amjms.2019.07.003 PubMed DOI

Kossoff EH, Zupec‐Kania BA, Auvin S, Ballaban‐Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;21:175–92. PubMed PMC

In vitro diagnostic test systems—requirements for blood‐glucose monitoring systems for self‐testing in managing diabetes mellitus [Internet]. International Organization for Standardization; 2018 [cited 2022 Feb 1]. Available from: https://www.iso.org/standard/54976.html

Collett D. Modelling survival data in medical research. 2nd ed. Boca Raton: Chapman & Hall/CRC; 2003.

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. Hoboken: Wiley; 2002.

R Core Team . R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2022.

Wand MP, Jones MC. Kernel smoothing. London: Chapman & Hall/CRC; 1995.

Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF. Brain metabolism during fasting. J Clin Invest. 1967;46(10):1589–95. PubMed PMC

Sokoloff L. Metabolism of ketone bodies by the brain. Annu Rev Med. 1973;24:271–80. PubMed

Randle P, Garland P, Hales C, Newsholme E. The glucose fatty‐acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;281(7285):785–9. PubMed

Clanton RM, Wu G, Akabani G, Aramayo R. Control of seizures by ketogenic diet‐induced modulation of metabolic pathways. Amino Acids. 2017;49(1):1–20. 10.1007/s00726-016-2336-7 PubMed DOI

Napoleão A, Fernandes L, Miranda C, Marum AP. Effects of calorie restriction on health span and insulin resistance: classic calorie restriction diet vs ketosis‐inducing diet. Nutrients. 2021;13(4):1302. PubMed PMC

Paoli A. Ketogenic diet for obesity: friend or foe? Int J Environ Res Public Health. 2014;11(2):2092–107. PubMed PMC

Christiansen M, Bailey T, Watkins E, Liljenquist D, Price D, Nakamura K, et al. A new‐generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous‐generation system. Diabetes Technol Ther. 2013;15(10):881–8. PubMed PMC

Ly TT, Gallego PH, Davis EA, Jones TW. Impaired awareness of hypoglycemia in a population‐based sample of children and adolescents with type 1 diabetes. Diabetes Care. 2009;32(10):1802–6. PubMed PMC

Graveling AJ, Frier BM. Impaired awareness of hypoglycaemia: a review. Diabetes Metab. 2010;36(Suppl 3):S64–74. PubMed

Seaquist ER, Teff K, Heller SR. Impaired awareness of hypoglycemia in type 1 diabetes: a report of an NIDDK Workshop in October 2021. Diabetes Care. 2022;45(12):2799–805. PubMed PMC